The US FDA has granted fast track designation to FELIQS’ lead product FLQ-101 for preventing retinopathy of prematurity (ROP) ...

corporate finance and investing. Do you want your investment decisions to have a positive impact? Do you find it difficult to ...

Apply the tools of corporate finance to boost your strategic decision-making. Making the strategic decisions that will determine the future expansion, restructuring or capital requirements of your ...

A commercial encouraging people to “break up” with their tax preparers drew responses from the AICPA and NATP as accounting's struggle with talent and technology continues. The a16z founder compared ...

The US FDA has granted orphan drug designation (ODD) to Modalis Therapeutics’ MDL-101, aimed at treating LAMA2-CMD.

WARMINSTER, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage ...

OKYO Pharma has initiated the Phase II trial of OK-101, a treatment for neuropathic corneal pain (NCP), by dosing the first ...

Discover SocialFi, a revolutionary blend of social media and finance, offering true digital ownership, monetization, and ...